Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
265 GBX | +6.00% | +23.26% | -13.11% |
11:18am | Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study | MT |
10:04am | Faron Pharma celebrates positive read-out in ongoing MDS trial | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.11% | 229M | |
+9.65% | 115B | |
+11.72% | 106B | |
-2.59% | 21.96B | |
-13.33% | 21.87B | |
-5.29% | 19.21B | |
-4.05% | 18.08B | |
-38.57% | 17.71B | |
+6.41% | 14.32B | |
+33.99% | 12.42B |
- Stock Market
- Equities
- FARN Stock
- News Faron Pharmaceuticals Oy
- Transcript : Faron Pharmaceuticals Oy - Special Call